Magellan Stock Analysis


USD 94.99  0.00  0.00%   

The latest indifference towards the small price fluctuations of Magellan Health may encourage institutional investors to take a closer look at the firm as it is trading at a share price of 94.99 on slow start in trading volume. The company executives did not add any value to Magellan Health investors in July. However, most investors can still diversify their portfolios with Magellan Health to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently very low. The very small Stock volatility is a good signal to institutional investors with longer-term investment horizons.
Additionally, see Stocks Correlation.
The Magellan Health stock analysis report makes it easy to digest most publicly released information about Magellan Health and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Magellan Stock analysis module also helps to analyze the Magellan Health price relationship with some important fundamental indicators such as market cap and management efficiency.

Magellan Stock Analysis Notes

About 103.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.29. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Magellan Health recorded earning per share (EPS) of 11.19. The entity had not issued any dividends in recent years. Magellan Health, Inc., together with its subsidiaries, provides healthcare management services in the United States. As of January 4, 2022, Magellan Health, Inc. operates as a subsidiary of Centene Corporation. Magellan Health operates under Healthcare Plans classification in the United States and is traded on NASDAQ Exchange. It employs 9000 people. To find out more about Magellan Health contact Barry Smith at 800 642-1716 or learn more at

Magellan Health Quarterly Cost of Revenue

1.22 Billion

Magellan Health Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Magellan Health's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Magellan Health or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Magellan Health is not currently marked as verified by its exchange. Report It!

Magellan Health Upcoming and Recent Events

Earnings reports are used by Magellan Health to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Magellan Health previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report25th of February 2022
Next Financial Report29th of April 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End25th of February 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Magellan Health SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Magellan Health prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Magellan Health investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Magellan Health specific information freely available to individual and institutional investors to make a timely investment decision.
6th of January 2022
Unclassified Corporate Event
4th of January 2022
Unclassified Corporate Event. Unclassified Corporate Event. Unclassified Corporate Event. Unclassified Corporate Event. Completion of Acquisition or Disposition of Assets
30th of December 2021
Financial Statements and Exhibits. Other Events
5th of November 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition

Magellan Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 2.5 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Magellan Health's market, we take the total number of its shares issued and multiply it by Magellan Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Magellan Profitablity

Magellan Health's profitability indicators refer to fundamental financial ratios that showcase Magellan Health's ability to generate income relative to its revenue or operating costs. If, let's say, Magellan Health is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Magellan Health's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Magellan Health's profitability requires more research than a typical breakdown of Magellan Health's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 6.26 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 0.6 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.01.
Last ReportedProjected for 2022
Return on Investment(0.69) (0.71) 
Return on Average Assets 0.10  0.11 
Return on Average Equity 0.21  0.23 
Return on Invested Capital 0.21  0.25 
Return on Sales 0.07  0.08 

Management Efficiency

The entity has return on total asset (ROA) of 0.54 % which means that it generated profit of $0.54 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (0.16) %, meaning that it created substantial loss on money invested by shareholders. Magellan Health management efficiency ratios could be used to measure how well magellan health manages its routine affairs as well as how well it operates its assets and liabilities. Magellan Health Return on Average Assets are quite stable at the moment as compared to the past year. The company's current value of Return on Average Assets is estimated at 0.11. Return on Average Equity is expected to rise to 0.23 this year, although the value of Return on Investment will most likely fall to (0.71) . Magellan Health Tax Assets are quite stable at the moment as compared to the past year. The company's current value of Tax Assets is estimated at 1.7 Million. Revenue to Assets is expected to rise to 1.99 this year, although the value of Total Assets will most likely fall to about 3.4 B.
Last ReportedProjected for 2022
Book Value per Share 83.98  71.62 
Enterprise Value over EBIT 8.05  11.99 
Enterprise Value over EBITDA 6.16  7.27 
Price to Book Value 1.02  1.14 
Tangible Assets Book Value per Share 108.07  91.75 
Enterprise ValueB2.6 B
Tangible Asset Value2.8 B2.3 B

Magellan Health Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Magellan Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Magellan Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Magellan Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Magellan Health Technical and Predictive Indicators

About Magellan Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Magellan Health stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Magellan shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Magellan Health. By using and applying Magellan Stock analysis, traders can create a robust methodology for identifying Magellan entry and exit points for their positions.
Last ReportedProjected for 2022
Operating Margin(0.34) (0.35) 
EBITDA Margin 0.1  0.08 
Gross Margin 0.0234  0.0345 
Profit Margin 0.08  0.08 
Magellan Health, Inc., together with its subsidiaries, provides healthcare management services in the United States. As of January 4, 2022, Magellan Health, Inc. operates as a subsidiary of Centene Corporation. Magellan Health operates under Healthcare Plans classification in the United States and is traded on NASDAQ Exchange. It employs 9000 people.

Current Magellan Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Magellan analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Magellan analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Magellan Health current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Magellan analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Magellan stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Magellan Health, talking to its executives and customers, or listening to Magellan conference calls.
Magellan Analyst Advice Details

Magellan Stock Analysis Indicators

Magellan Health stock analysis indicators help investors evaluate how Magellan Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Magellan Health shares will generate the highest return on investment. By understating and applying Magellan Health stock analysis, traders can identify Magellan Health position entry and exit signals to maximize returns.
Quick Ratio2.44
Fifty Two Week Low82.94
Revenue Growth7.20%
Shares Short Prior Month1.53M
Average Daily Volume Last 10 Day189.55k
Average Daily Volume In Three Month138.47k
Earnings Growth-93.30%
Shares Percent Shares Out4.40%
Earnings Quarterly Growth-49.00%
Gross Margins2.55%
Short Percent Of Float5.71%
Forward Price Earnings27.86
Float Shares23.55M
Fifty Two Week High99.36
Enterprise Value To Ebitda24.10
Fifty Day Average94.69
Two Hundred Day Average94.45
Enterprise Value To Revenue0.43
Additionally, see Stocks Correlation. Note that the Magellan Health information on this page should be used as a complementary analysis to other Magellan Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Tools for Magellan Stock

When running Magellan Health price analysis, check to measure Magellan Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Magellan Health is operating at the current time. Most of Magellan Health's value examination focuses on studying past and present price action to predict the probability of Magellan Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Magellan Health's price. Additionally, you may evaluate how the addition of Magellan Health to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world